LSE - Delayed Quote GBp

Shield Therapeutics plc (STX.L)

1.4250 -0.0500 (-3.39%)
At close: April 22 at 4:17 PM GMT+1
Currency in GBP All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
6,187.0000
4,467.0000
1,519.0000
10,387.0000
Cost of Revenue
3,416.0000
2,470.0000
980.0000
1,354.0000
Gross Profit
2,771.0000
1,997.0000
539.0000
9,033.0000
Operating Expense
24,976.0000
27,704.0000
20,833.0000
11,187.0000
Operating Income
-22,205.0000
-25,707.0000
-20,294.0000
-2,154.0000
Net Non Operating Interest Income Expense
-937.0000
-304.0000
5.0000
2.0000
Pretax Income
-37,213.0000
-40,082.0000
-19,907.0000
-1,886.0000
Tax Provision
718.0000
362.0000
-229.0000
744.0000
Net Income Common Stockholders
-37,931.0000
-40,444.0000
-19,678.0000
-2,630.0000
Diluted NI Available to Com Stockholders
-37,931.0000
-40,444.0000
-19,678.0000
-2,630.0000
Basic EPS
-0.12
-0.17
-0.10
-0.02
Diluted EPS
-0.12
-0.17
-0.10
-0.02
Basic Average Shares
476,634.2460
237,905.8820
204,409.0000
120,682.0580
Diluted Average Shares
476,634.2460
237,905.8820
204,409.0000
120,682.0580
Total Operating Income as Reported
-36,912.0000
-40,414.0000
-20,294.0000
-2,154.0000
Rent Expense Supplemental
--
122.0000
73.0000
48.0000
Total Expenses
28,392.0000
30,174.0000
21,813.0000
12,541.0000
Net Income from Continuing & Discontinued Operation
-37,931.0000
-40,444.0000
-19,678.0000
-2,630.0000
Normalized Income
-26,017.5200
-28,530.5200
-19,678.0000
-2,630.0000
Interest Income
-25.0000
30.0000
13.0000
3.0000
Interest Expense
905.0000
327.0000
--
--
Net Interest Income
-937.0000
-304.0000
5.0000
2.0000
EBIT
-36,308.0000
-39,755.0000
-19,907.0000
-1,886.0000
EBITDA
-34,740.0000
-37,393.0000
-17,700.0000
819.0000
Reconciled Cost of Revenue
3,416.0000
2,470.0000
980.0000
1,354.0000
Reconciled Depreciation
1,568.0000
2,362.0000
2,207.0000
2,705.0000
Net Income from Continuing Operation Net Minority Interest
-37,931.0000
-40,444.0000
-19,678.0000
-2,630.0000
Total Unusual Items Excluding Goodwill
-14,708.0000
-14,708.0000
--
--
Total Unusual Items
-14,708.0000
-14,708.0000
--
--
Normalized EBITDA
-20,032.0000
-22,685.0000
-17,700.0000
819.0000
Tax Rate for Calcs
0.0002
0.0002
0.0000
0.0002
Tax Effect of Unusual Items
-2,794.5200
-2,794.5200
--
--
12/31/2020 - 2/26/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MXC.L Argent BioPharma Limited
22.00
0.00%
 
KLAR.ST Klaria Pharma Holding AB (publ.)
0.2790
+13.88%
 
N4P.L N4 Pharma Plc
0.8500
0.00%
 
RMTI Rockwell Medical, Inc.
1.5150
+4.48%
 
IRWD Ironwood Pharmaceuticals, Inc.
8.06
+1.77%
 
ESPR Esperion Therapeutics, Inc.
1.9100
-2.05%
 
VTRS Viatris Inc.
11.25
0.00%